There is a new study of a testosterone bioadhesive buccal tablet for testosterone replacement in men with testosterone deficiency. The 3-month study will evaluate the safety and efficacy of this new form of testosterone therapy. The tablet is applied twice daily and is designed to deliver testosterone into the circulation at normal physiologic levels. This Phase III study is being conducted at nine sites throughout the United States.
Recruitment is on-going.
Potential candidates need to be in relatively good health, have very low testosterone levels without treatment, be between 18-80 years old and be able to come to the clinic monthly for examination and testing. Interested persons should contact the site coordinator nearest them for additional information.